NCT05385861 2025-08-15
Nal-IRI (ONIVYDE® ) and Carboplatin in Patients With Advanced or Metastatic GEP-NET
National Health Research Institutes, Taiwan
Phase 1/2 Enrolling by invitation
Clinical Trials
1 trialsEnrolling by invitation × Gastro-enteropancreatic neuroendocrine tumor × irinotecan sucrosofate × Clear all